These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 16076684
1. Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies. Hokkanen S, Kosunen TU, Sarna S, Miettinen A, Salomaa A, Aromaa A, Knekt P, Rautelin HI. Scand J Clin Lab Invest; 2005; 65(4):291-9. PubMed ID: 16076684 [Abstract] [Full Text] [Related]
2. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M. Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091 [Abstract] [Full Text] [Related]
3. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy. Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, Ishii H, Hibi T. Hepatogastroenterology; 2004 Jul; 51(59):1249-54. PubMed ID: 15362725 [Abstract] [Full Text] [Related]
4. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K. J Gastroenterol; 2003 Jul; 38(4):332-8. PubMed ID: 12743772 [Abstract] [Full Text] [Related]
5. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma. Sugiu K, Kamada T, Ito M, Kaya S, Tanaka A, Kusunoki H, Hata J, Haruma K. Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394 [Abstract] [Full Text] [Related]
6. Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study. Di Mario F, Moussa AM, Dal Bò N, Caruana P, Pilotto A, Cavallaro LG, Cavestro GM, Iori V, Merli R, Franzé A, Rugge M. J Gastroenterol Hepatol; 2005 Nov; 20(11):1661-6. PubMed ID: 16246182 [Abstract] [Full Text] [Related]
7. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. Cao Q, Ran ZH, Xiao SD. J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130 [Abstract] [Full Text] [Related]
8. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis. Bölükbaş C, Bölükbaş FF, Ovünç O, Kiliç G, Dalay R, Güven H, Uras F, Yardimci TK, Sökmen MH, Agan AF, Pişkinpaşa N. Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249 [Abstract] [Full Text] [Related]
9. Prevalence of Helicobacter pylori infection and atrophic gastritis in Latvia. Leja M, Cine E, Rudzite D, Vilkoite I, Huttunen T, Daugule I, Rumba-Rozenfelde I, Pimanov S, Liepniece-Karele I, Pahomova J, Purmalis K, Eglitis J, Pirags V, Dzerve V, Erglis A. Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1410-7. PubMed ID: 23114744 [Abstract] [Full Text] [Related]
10. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients. Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N. Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602 [Abstract] [Full Text] [Related]
11. Organ-specific autoantibodies in children with Helicobacter pylori infection. Guariso G, Brotto F, Basso D, Alaggio R, Betterle C. Helicobacter; 2004 Dec; 9(6):622-8. PubMed ID: 15610075 [Abstract] [Full Text] [Related]
12. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV. J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360 [Abstract] [Full Text] [Related]
13. Effect of Bifidobacterium bifidum fermented milk on Helicobacter pylori and serum pepsinogen levels in humans. Miki K, Urita Y, Ishikawa F, Iino T, Shibahara-Sone H, Akahoshi R, Mizusawa S, Nose A, Nozaki D, Hirano K, Nonaka C, Yokokura T. J Dairy Sci; 2007 Jun; 90(6):2630-40. PubMed ID: 17517703 [Abstract] [Full Text] [Related]
14. Serum gastrin, pepsinogens, parietal cell and Helicobacter pylori antibodies in patients with gastric polyps. Bonilla Palacios JJ, Miyazaki Y, Kanayuma S, Yasunaga Y, Matsuzawa Y. Acta Gastroenterol Latinoam; 1994 Jun; 24(2):77-82. PubMed ID: 7817697 [Abstract] [Full Text] [Related]
15. Is GastroPanel serum assay useful in the diagnosis of Helicobacter pylori infection and associated gastritis in children? Koivusalo AI, Pakarinen MP, Kolho KL. Diagn Microbiol Infect Dis; 2007 Jan; 57(1):35-8. PubMed ID: 16949782 [Abstract] [Full Text] [Related]
16. Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries. De Vries AC, Van Driel HF, Richardus JH, Ouwendijk M, Van Vuuren AJ, De Man RA, Kuipers EJ. Scand J Gastroenterol; 2008 Jan; 43(4):403-9. PubMed ID: 18365904 [Abstract] [Full Text] [Related]
17. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Hershko C, Hoffbrand AV, Keret D, Souroujon M, Maschler I, Monselise Y, Lahad A. Haematologica; 2005 May; 90(5):585-95. PubMed ID: 15921373 [Abstract] [Full Text] [Related]
18. Serum pepsinogen levels, Helicobacter pylori CagA Status, and cytokine gene polymorphisms associated with gastric premalignant lesions in Costa Rica. Con SA, Con-Wong R, Con-Chin GR, Con-Chin VG, Takeuchi H, Valerín AL, Echandi G, Mena F, Brenes F, Yasuda N, Araki K, Sugiura T. Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2631-6. PubMed ID: 18086767 [Abstract] [Full Text] [Related]
19. Serum pepsinogen levels in the Japanese population: prospective study of 9 years of follow-up. Xie XF, Ito M, Yoshihara M, Haruma K, Tanaka S, Chayama K. Hepatogastroenterology; 2007 Sep; 54(78):1887-90. PubMed ID: 18019741 [Abstract] [Full Text] [Related]
20. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay. Sun LP, Gong YH, Wang L, Gong W, Yuan Y. J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790 [Abstract] [Full Text] [Related] Page: [Next] [New Search]